Article Details

Northland Securities Trims Nabriva Therapeutics (NASDAQ:NBRV) Target Price to $6.00

Retrieved on: 2021-03-12 13:18:45

Tags for this article:

Click the tags to see associated articles and topics

Northland Securities Trims Nabriva Therapeutics (NASDAQ:NBRV) Target Price to $6.00. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 342,360 shares of the biotechnology company's stock worth $829,000 after purchasing an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo